In the world of medical supplies, precision and quality are crucial. Foosin Medical Products Co., Ltd., a joint venture between Weigao Group and Hong Kong, is at the forefront of the surgical suture revolution. Foosin Company was established in 2005 with a total capital of more than 50 million yuan and is committed to becoming the most powerful manufacturing base for surgical needles and sutures in developed countries. Their main products include surgical sutures, surgical needles and dressings, all of which are designed to meet the highest medical standards.
Weigao, the parent company of Foosin is a giant in the medical industry. It has more than 80 subsidiaries, 2 listed companies, and more than 30,000 employees. WEGO’s diversified industry group includes medical products, blood purification, orthopedics, medical equipment, pharmaceuticals, cardiac consumables, medical business, etc. Extensive networks and expertise make WEGO and Foosin eaders in the development and production of cutting-edge medical supplies.
The collaboration between WEGO and Foosin produces surgical sutures that set new standards in the industry. With a focus on innovation and precision, these sutures are crafted to ensure optimal performance during surgical procedures. WEGO’s industry expertise combines with Foosin’s dedication to quality to create sutures that meet the stringent requirements of modern healthcare.
As the demand for advanced medical supplies continues to grow, WEGO and Foosin are committed to meeting the needs of healthcare professionals and patients. By leveraging their collective resources and expertise, they are poised to make a significant impact in the field of surgical sutures and medical supplies. With a focus on excellence and a dedication to innovation, the collaboration between WEGO and Foosin is shaping the future of surgical sutures.
Post time: May-24-2024